• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA PLUS BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA PLUS BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00523500
Device Problems Break (1069); Mechanical Problem (1384); Stretched (1601); Use of Device Problem (1670); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/28/2023
Event Type  malfunction  
Event Description
It was reported to boston scientific corporation that a flexima plus biliary stent was implanted in the left side of the common bile duct during an endoscopic biliary drainage procedure performed on (gb)(6) 2023.During the procedure, the touhy borst was too stiff to disengage before release, and the guide catheter was stretched.The procedure was completed with the original device.There were no patient complications reported as a result of this event.Note: it was reported that the guidewire was inside the patient during the attempted deployment.However, the flexima plus duodenal bend biliary stent with delivery system instructions for use (ifu) states, "to deploy the stent, loosen the tuohy-borst adapter slightly and pull on the guide catheter luer-lok hub and guidewire.Hold the outer positioner stationary, while gently retracting the inner guide catheter and guidewire.Endoscopically monitor the stent position.Warning: if the guidewire is not completely retracted into the delivery system, the stent can not be fully deployed." the physician did not follow the steps cited in the ifu.This event has been deemed an mdr-reportable event based on the investigation finding of a detached guide catheter.Please see block h10 for the full investigation details.
 
Manufacturer Narrative
Block h6: imdrf device code a0401: captures the reportable investigation finding of a guide catheter break.Block h10: the flexima plus biliary stent delivery system was returned for analysis.Visual inspection found that the guide catheter was detached from the push catheter.Microscopic and visual inspections found that the guide catheter was stretched and kinked, the suture hole of the push catheter was torn, and the touhy borst was damaged and detached.No other damages were noted with the delivery system.Product analysis confirmed the reported event of a guide catheter being stretched; however, the reported event of a touhy borst failure to loosen was not confirmed because the condition of the returned device indicated that the physician loosened the incorrect section of the device.Additionally, a labeling review was performed, and from the information available, this device was used in a manner inconsistent with the instructions for use (ifu)/product label.It was reported that the guidewire was inside the patient during the attempted deployment.However, the flexima plus duodenal bend biliary stent with delivery system instructions for use (ifu) states, "to deploy the stent, loosen the tuohy-borst adapter slightly and pull on the guide catheter luer-lok hub and guidewire.Hold the outer positioner stationary, while gently retracting the inner guide catheter and guidewire.Endoscopically monitor the stent position.Warning: if the guidewire is not completely retracted into the delivery system, the stent cannot be fully deployed." the investigation concluded that the stretching of the guide catheter and the additional investigation findings of guide catheter detachment and kinking and push catheter suture hole torn were most likely due to procedural factors such as lesion characteristics, the handling of the device, and the technique used by the physician (force applied).Therefore, a review and analysis of all available information indicated that the most probable cause is adverse event related to procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA PLUS BILIARY
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18866935
MDR Text Key337319758
Report Number3005099803-2024-00859
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K965147
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 03/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM00523500
Device Catalogue Number2350
Device Lot Number0028011394
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/12/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-